Loading...
•
Aug 31, 2025
AngioDynamics Q1 2026 Earnings Report
AngioDynamics reported its fiscal year 2026 first quarter financial results, driven by strong Med Tech growth.
Key Takeaways
AngioDynamics delivered an outstanding first quarter for fiscal year 2026, with net sales increasing by 12.2% to $75.7 million. The Med Tech segment continued its strong momentum with 26.1% revenue growth, marking its fourth consecutive quarter of over 20% growth. The company also reported positive Adjusted EBITDA of $2.2 million, a significant improvement from a loss in the prior year, and ended the quarter with $38.8 million in cash and cash equivalents, ahead of expectations.
Net sales for Q1 FY26 reached $75.7 million, an increase of 12.2% compared to the prior-year quarter.
Med Tech net sales grew by 26.1% to $35.3 million, driven by strong performance in Auryon, Mechanical Thrombectomy, and NanoKnife platforms.
Adjusted EBITDA was $2.2 million, a substantial improvement from ($0.2) million in the first quarter of fiscal 2025.
The company reported a GAAP loss per share of $0.26 and an adjusted loss per share of $0.10.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
AngioDynamics raised its full fiscal year 2026 guidance for net sales, Med Tech net sales growth, Adjusted EBITDA, and Adjusted EPS, while maintaining expectations for gross margin and positive free cash flow.
Positive Outlook
- Increased full year FY 2026 net sales guidance to $308 - $313 million (from $305 - $310 million).
- Raised Med Tech net sales growth guidance to 14% - 16% (from 12% - 15%).
- Increased Adjusted EBITDA guidance to $6.0 - $10.0 million (from $3.0 - $8.0 million).
- Improved Adjusted EPS guidance to ($0.33) – ($0.23) (from ($0.35) – ($0.25)).
- Continues to expect to be cash flow positive for the full fiscal year 2026.
Challenges Ahead
- Med Device net sales growth guidance remains unchanged at flat.
- Gross Margin guidance remains unchanged at 53.5% - 55.5%.
- Anticipates a $4.0 - $6.0 million impact from tariffs for the full fiscal year 2026.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...